Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting unaudited standalone and consolidated financial results of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amal Ltd reported its Q3 FY26 and 9M FY26 unaudited results along with a clean limited review report from Deloitte Haskins & Sells LLP. Standalone revenue from operations rose 36% year-on-year to Rs 2,200.73 lakh (Q3) and 9M revenue grew nearly 60% to Rs 5,488.52 lakh. Consolidated revenue surged about 70% YoY to Rs 16,390.14 lakh for the 9-month period, driven by subsidiary Amal Speciality Chemicals. However, profitability fell sharply: standalone Q3 net profit dropped 62% YoY to Rs 144.82 lakh and 9M standalone PAT fell to Rs 272.77 lakh from Rs 486.71 lakh, as cost of materials consumed more than doubled. Consolidated 9M PAT slipped to Rs 2,048.14 lakh from Rs 2,251.37 lakh. An additional Rs 8.94 lakh (standalone) / Rs 14.10 lakh (consolidated) was provided toward retirement benefits due to the new Labour Codes effective Nov 21, 2025.
Strong top-line growth from the bulk chemicals subsidiary is positive, but steep rise in raw material costs has hit operating margins hard, weighing on near-term profitability. Investors should watch whether input cost pressures ease and margins recover in the coming quarter.